Chronic Pruritus in Older Adults: Emerging Mechanisms

Abstract

Chronic pruritus (CP) is a frequently encountered and often debilitating symptom among older adults, presenting unique diagnostic and therapeutic challenges. This review synthesizes current evidence on the epidemiology, pathophysiology, risk factors, clinical features, diagnosis, management strategies, and recent advances regarding chronic pruritus in the elderly. Emphasis is placed on emerging mechanisms, including age-related skin changes, neuroimmune dysregulation, and systemic contributors, to inform the optimization of care for this vulnerable population.

Introduction

Chronic pruritus, defined as itching persisting for at least six weeks, represents a significant clinical concern in geriatric medicine. The prevalence of CP increases with age and is associated with diminished quality of life, sleep disturbance, and psychological morbidity. The multifactorial nature of pruritus in older adults necessitates a comprehensive understanding of its underlying mechanisms, differential diagnosis, and evidence-based management. Recent research has elucidated novel pathophysiological pathways and therapeutic targets, underscoring the importance of updated, mechanism-based approaches in clinical practice.

Epidemiology / Disease Burden

Chronic pruritus affects up to 20% of individuals over the age of 65 and is more prevalent in institutionalized elderly populations. The burden of CP extends beyond cutaneous discomfort, contributing to secondary excoriations, infection risk, sleep disturbances, and impaired psychosocial functioning. Epidemiological studies highlight a higher incidence of pruritus among elderly patients with comorbidities such as chronic kidney disease, diabetes, and malignancy. The projected growth of the aging population portends an increasing healthcare burden related to CP, emphasizing the need for targeted research and resource allocation.

Pathophysiology

The pathophysiology of chronic pruritus in older adults is multifactorial, involving complex interactions between cutaneous, neural, and systemic factors. Age-related xerosis, characterized by decreased epidermal lipid content and impaired skin barrier, is a predominant contributor. Recent insights reveal that neuroimmune dysregulation, including altered expression of pruritogenic cytokines (e.g., interleukin-31), and changes in cutaneous nerve fiber density further exacerbate itch perception. Systemic factors, such as chronic renal insufficiency, hepatic dysfunction, and hematological malignancies, may promote pruritus through the accumulation of pruritogens and systemic inflammation. Notably, age-associated changes in sensory neuron function and central nervous system processing appear to amplify pruritic stimuli, reinforcing the need for mechanism-based therapeutic strategies.

Risk Factors

Key risk factors for chronic pruritus in older adults encompass intrinsic aging processes, comorbid dermatological conditions (e.g., atopic dermatitis, psoriasis), systemic diseases (renal, hepatic, hematologic), polypharmacy, and environmental exposures leading to xerosis. Medications such as diuretics, statins, and opioid analgesics may precipitate or exacerbate pruritus via direct or indirect mechanisms. Frailty, reduced mobility, and cognitive impairment can further contribute to the persistence and severity of symptoms by impeding effective self-care and access to medical evaluation.

Clinical Features

CP in older adults typically presents as generalized or localized itching, often without primary skin lesions. Secondary changes, including excoriations, lichenification, and prurigo nodularis, may develop due to chronic scratching. The absence of visible skin findings necessitates thorough evaluation for systemic causes. Associated symptoms such as sleep disruption, mood disturbance, and reduced quality of life are common and warrant targeted assessment. Clinical heterogeneity underscores the importance of individualized diagnostic and management approaches.

Diagnosis

Evaluation of chronic pruritus in the elderly begins with a comprehensive history and physical examination, focusing on pruritus characteristics, onset, distribution, exacerbating factors, and associated systemic symptoms. Laboratory investigations should include complete blood count, renal and hepatic function tests, thyroid profile, and, when indicated, serum protein electrophoresis and chest imaging. Skin biopsy may be warranted in cases of unexplained dermatosis or suspected malignancy. Collaboration with multidisciplinary teams is essential in complex or refractory cases to identify underlying etiologies and optimize care.

Treatment & Management

Management of chronic pruritus in older adults is predicated on the identification and treatment of underlying causes, symptomatic relief, and prevention of complications. Emollients and gentle skin care are foundational in addressing xerosis. Topical corticosteroids or calcineurin inhibitors may be indicated for inflammatory dermatoses. Systemic agents, such as antihistamines, gabapentinoids, or selective serotonin reuptake inhibitors (SSRIs), should be selected judiciously, with consideration of comorbidities and polypharmacy. Non-pharmacologic interventions, including phototherapy and cognitive behavioral therapy, may benefit select patients. Patient education on skin care, avoidance of irritants, and adherence to therapeutic regimens is crucial for sustained symptom control.

Recent Advances / Emerging Therapies

Recent advances in the management of chronic pruritus include the development of targeted biologics, such as anti-IL-31 receptor antibodies (e.g., nemolizumab), which have demonstrated efficacy in atopic and prurigo nodularis-associated itch. Novel small molecules targeting pruritic pathways, including kappa-opioid receptor agonists and Janus kinase (JAK) inhibitors, are under investigation and offer promise for refractory cases. Improved understanding of the neuroimmune axis has catalyzed research into new topical and systemic agents with favorable safety profiles for older adults. Ongoing clinical trials are expected to further refine therapeutic algorithms and expand the repertoire of evidence-based options.

Guideline Recommendations

Recent clinical guidelines advocate a stepwise, mechanism-based approach to the management of chronic pruritus in the elderly. Initial assessment should prioritize the identification and treatment of reversible etiologies, with subsequent escalation to topical and systemic therapies as needed. Emphasis is placed on minimizing polypharmacy, optimizing skin barrier function, and addressing comorbid psychological and sleep disturbances. Multidisciplinary collaboration and individualized care plans are recommended to achieve optimal outcomes and minimize adverse effects.

Conclusion

Chronic pruritus in older adults is a complex, multifaceted condition with significant clinical and psychosocial implications. Advances in the understanding of its underlying mechanisms have informed the development of novel diagnostic and therapeutic strategies. A comprehensive, patient-centered approach, integrating recent evidence and guideline-based recommendations, is essential for effective management. Continued research into emerging mechanisms and innovative therapies holds promise for improving the quality of life of this growing patient population.